Patents by Inventor John Vidmar

John Vidmar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR PREPARING EXTRACTS FROM PLANTS AND FUNGI
    Publication number: 20220362320
    Abstract: Extracts of a plant, fungus, waste, or part thereof, compositions comprising same, and methods of preparing and using same are provided. Extraction may be conducted using acetone/water extraction solution at predetermined ratios to yield extracts comprising desired phytocannabinoids, cannabimimetic compounds, terpenes, flavonoids, alkaloids, waxes, and other secondary metabolites. A composition comprises the extract and at least one acceptable carrier. A method of treating, preventing, or ameliorating a disease in a subject comprises administering to the subject an effective amount of the extract or composition.
    Type: Application
    Filed: May 2, 2022
    Publication date: November 17, 2022
    Applicant: Canna Stream Solutions Ltd.
    Inventors: Behzad AHVAZI, Usukuma Ekuere, Krista Leicht, Joseph John Vidmar
  • Variegation in plants
    Patent number: 9145562
    Abstract: A variegated plant comprising a nucleic acid operatively linked to a regulatory region, the nucleic acid disrupts the expression of Cpn21. The nucleic acid is typically an antisense Cpn21 and the regulatory region may be an inducible regulatory region, a tissue specific regulatory region, or a developmental regulatory region.
    Type: Grant
    Filed: November 20, 2009
    Date of Patent: September 29, 2015
    Assignee: ALBERTA INNOVATES—TECHNOLOGY FUTURES
    Inventors: Margarita Velcheva, John Vidmar, Jurgen Quandt
  • Variegation in plants
    Publication number: 20110126311
    Abstract: A variegated plant comprising a nucleic acid operatively linked to a regulatory region, the nucleic acid disrupts the expression of Cpn21. The nucleic acid is typically an antisense Cpn21 and the regulatory region may be an inducible regulatory region, a tissue specific regulatory region, or a developmental regulatory region.
    Type: Application
    Filed: November 20, 2009
    Publication date: May 26, 2011
    Applicant: Alberta Research Council Inc.
    Inventors: Margarita Velcheva, John Vidmar, Jurgen Quandt